Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Roche Calls For Harmonized Regulations As Subcutaneous Herceptin Declined Trial Waiver In India

Jan 18 2019

• By Anju Ghangurde

BASEL, SWITZERLAND - APR 17: Roche headquarters on April 19, 2013 in Basel, Switzerland. Rocheis a Swiss global pharma company that operates worldwide producing pharmaceuticals and diagnostics. — HERCEPTIN SC DECLINED A TRIAL WAIVER IN INDIA

Related Content

Products Roundup - 19 December 2018: European Commission Approves Mylan/Biocon’s Ogivri Biosimilar, Amgen Files Infliximab With The FDA And Hikma Debuts Dalfampridine

Dec 19 2018

Keeping Track: FDA Clears Motegrity And Second Herceptin Biosimilar, But Rebuffs SpecGx's Oxycodone

Dec 17 2018

Roche India Mandate 'Completely Different' Says New Head Bezzera

Apr 09 2018

Related Companies

Roche Holding AG

Biocon, Ltd.

Viatris Inc.

Zydus Lifesciences Limited

Additional Topics

India Asia Pacific Policy Review Pathway BioPharmaceutical

More from India

More from Asia

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window